Arbutus Biopharma Corp (ABUS)

3.92 +0.06 (+1.55%) USD  |  NASDAQ  |  Nov 05, 14:31
More

Arbutus Biopharma EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Free Cash Flow Data

View and export this data back to 2008. Upgrade now.
Date Value
November 04, 2024 --
November 01, 2024 --
October 31, 2024 --
October 30, 2024 --
October 29, 2024 --
October 28, 2024 --
October 25, 2024 --
October 24, 2024 --
October 23, 2024 --
October 22, 2024 --
October 21, 2024 --
October 18, 2024 --
October 17, 2024 --
October 16, 2024 --
October 15, 2024 --
October 14, 2024 --
October 11, 2024 --
October 10, 2024 --
October 09, 2024 --
October 08, 2024 --
October 07, 2024 --
October 04, 2024 --
October 03, 2024 --
October 02, 2024 --
October 01, 2024 --
Date Value
September 30, 2024 --
September 27, 2024 --
September 26, 2024 --
September 25, 2024 --
September 24, 2024 --
September 23, 2024 --
September 20, 2024 --
September 19, 2024 --
September 18, 2024 --
September 17, 2024 --
September 16, 2024 --
September 13, 2024 --
September 12, 2024 --
September 11, 2024 --
September 10, 2024 --
September 09, 2024 --
September 06, 2024 --
September 05, 2024 --
September 04, 2024 --
September 03, 2024 --
August 30, 2024 --
August 29, 2024 --
August 28, 2024 --
August 27, 2024 --
August 26, 2024 --

EV to Free Cash Flow Range, Past 5 Years

Upgrade
Minimum
Dec 01 2021
Upgrade
Maximum
Nov 07 2019
Upgrade
Average
Upgrade
Median
Oct 18 2022

EV to Free Cash Flow Benchmarks

Biomarin Pharmaceutical Inc Upgrade
GlycoMimetics Inc Upgrade
FibroGen Inc Upgrade
Cidara Therapeutics Inc Upgrade
Cue Biopharma Inc Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade